OCULAR THERAPEUTIX, INC 8-K

What Happened
Ocular Therapeutix, Inc. (OCUL) announced its financial results for the quarter and year ended December 31, 2025 via a press release dated February 5, 2026. The company furnished the full press release as Exhibit 99.1 to its Form 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: February 5, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter and year ended December 31, 2025.
• Press release included as Exhibit 99.1 to the Current Report on Form 8-K.
• The filing furnishes the company's reported results and related disclosures; investors should review Exhibit 99.1 for the detailed figures and commentary.

Why It Matters
This 8-K signals Ocular Therapeutix has publicly disclosed its latest earnings and financial condition, which typically include revenue, profit/loss, cash position and operational updates relevant to shareholders. Retail investors should read the attached press release (Exhibit 99.1) and any subsequent SEC filings for the specific earnings figures, guidance and management commentary to assess the company’s quarterly and full-year performance.